TOLRENBU
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Sept 2024)
What this means for you
This application is over — abandoned 02 Sept 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97235651
- Mark type
- Stylized text
- Filed
- 24 Jan 2022
- Published for opposition
- 06 Dec 2022
- Abandoned
- 02 Sept 2024
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations for the treatment of anemia; pharmaceuticals for the treatment of anemia
Owner
- Akebia Therapeutics, Inc., Cambridge, MA, US
- Akebia Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 02 Sept 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Sept 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Nov 2023 — SOU EXTENSION 2 GRANTED
- 29 Nov 2023 — SOU EXTENSION 2 FILED
- 29 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 08 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jun 2023 — SOU EXTENSION 1 GRANTED
- 06 Jun 2023 — SOU EXTENSION 1 FILED
- 06 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 18 Apr 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 Apr 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Apr 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 31 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED